Medication errors in chemotherapy: Incidence, types and involvement of patients in prevention. A review of the literature

European Journal of Cancer Care

Volumn 19, Issue 3, 2010, Pages 285-292

  Schwappach, D L B ^a,b   Wernli, M ^c  

^a Swiss Patient Safety Foundation   (Switzerland)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Chemotherapy; Medication errors; Patient participation; Patient safety

Indexed keywords

ANTINEOPLASTIC AGENT;

HUMAN; INCIDENCE; MEDICATION ERROR; NEOPLASM; PATIENT PARTICIPATION; REVIEW; SAFETY; STATISTICS;

ANTINEOPLASTIC AGENTS; HUMANS; INCIDENCE; MEDICATION ERRORS; NEOPLASMS; PATIENT PARTICIPATION; SAFETY;

EID: 77953144621     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01127.x     Document Type: Review

References (46)

1. Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, Etchells E, Ghali WA, Hebert P, Majumdar SR, O'Beirne M, Palacios-Derflingher L, Reid RJ, Sheps S, Tamblyn R. The Canadian Adverse Events Study: the incidence of Adverse Events among hospital patients in Canada. Canadian Medical Association Journal 2004, 170:1678-1686.
2. Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag D. Patient online self-reporting of toxicity symptoms during chemotherapy. Journal of Clinical Oncology 2005, 23:3552-3561.
3. Basch E, Artz D, Iasonos A, Speakman J, Shannon K, Lin K, Pun C, Yong H, Fearn P, Barz A, Scher HI, McCabe M, Schrag D. Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. Journal of the American Medical Informatics Association 2007, 14:264-268.
4. Coulter A. Patient safety: what role can patients play? Health Expectations 2006, 9:205-206.
5. Davis RE, Jacklin R, Sevdalis N, Vincent CA. Patient involvement in patient safety: what factors influence patient participation and engagement? Health Expectations 2007, 10:259-267.
6. Davis RE, Koutantji M, Vincent CA. How willing are patients to question healthcare staff on issues related to the quality and safety of their healthcare? An exploratory study. Quality and Safety in Health Care 2008, 17:90-96.
7. Dinning C, Branowicki P, O'Neill JB, Marino BL, Billett A. Chemotherapy error reduction: a multidisciplinary approach to create templated order sets. Journal of Pediatric Oncology Nursing 2005, 22:20-30.
8. Entwistle VA. Differing perspectives on patient involvement in patient safety. Quality and Safety in Health Care 2007, 16:82-83.
9. Finkelstein JB. E-prescribing first step to improved safety. Journal of the National Cancer Institute 2006, 98:1763-1765.
10. Ford CD, Killebrew J, Fugitt P, Jacobsen J, Prystas EM. Study of medication errors on a community hospital oncology ward. Journal of Oncology Practice 2006, 2:149-154.
11. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, Khan A, van Walraven C. Adverse events among medical patients after discharge from hospital. Canadian Medical Association Journal 2004, 170:345-349.
12. Fränneby U, Sandblom G, Nyren O, Nordin P, Gunnarsson U. Self-reported adverse events after groin hernia repair, a study based on a national register. Value in Health 2008, 11:927-932.
13. Gandhi TK, Bartel SB, Shulman LN, Verrier D, Burdick E, Cleary A, Rothschild JM, Leape LL, Bates DW. Medication safety in the ambulatory chemotherapy setting. Cancer 2005, 104:2477-2483.
14. Garcia C, Brach C. Integrating health literacy into patient safety partnerships. Engaging Patients as Safety Partners 2008, 121-162. Spath PL, In, ed., pp., AHA Press, Chicago, IL, USA
15. Hibbard JH, Peters E, Slovic P, Tusler M. Can patients be part of the solution? Views on their role in preventing medical errors. Medical Care Research and Review 2005, 62:601-616.
16. To Err Ishuman. Building A Safer Health System 2000, Institute of Medicine, National Academy Press, Washington, DC, USA
17. Kim GR, Chen AR, Arceci RJ, Mitchell SH, Kokoszka KM, Daniel D, Lehmann CU. Error reduction in pediatric chemotherapy: computerized order entry and failure modes and effects analysis. Archives of Pediatric and Adolescent Medicine 2006, 160:495-498.
18. Kloth DD. Prevention of chemotherapy medication errors. Journal of Pharmacy Practice 2002, 15:17-31.
19. Kopp BJ, Erstad BL, Allen ME, Theodorou AA, Priestley G. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Critical Care Medicine 2006, 34:415-425.
20. Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL. Role of computerized physician order entry systems in facilitating medication errors. Journal of the American Medical Association 2005, 293:1197-1203.
21. von Laue NC, Schwappach DL, Koeck CM. The epidemiology of medical errors: a review of the literature. Wiener Klinische Wochenschrift 2003a, 115:318-325.
22. von Laue NC, Schwappach DL, Koeck CM. The epidemiology of preventable adverse drug events: a review of the literature. Wiener Klinische Wochenschrift 2003b, 115:407-415.
23. Lustig A. Medication error prevention by pharmacists - an Israeli solution. Pharmacy World and Science 2000, 22:21-25.
24. Muller T. Typical medication errors in oncology: analysis and prevention strategies. Onkologie 2003, 26:539-544.
25. Nau DP, Erickson SR. Medication safety: patients' experiences, beliefs, and behaviors. Journal of the American Pharmaceutical Association 2005, 45:452-457.
26. Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Archives of Internal Medicine 2005, 165:1111-1116.
27. Peters E, Slovic P, Hibbard JH, Tusler M. Why worry? Worry, risk perceptions, and willingness to act to reduce medical errors. Health Psychology 2006, 25:144-152.
28. Pichon R, Zelger GL, Wacker P, Vodoz AL, Humbert J. Analysis and quantification of prescribing and transcription errors in a paediatric oncology service. Pharmacy World and Science 2002, 24:12-15.
29. Rinke ML, Shore AD, Morlock L, Hicks RW, Miller MR. Characteristics of pediatric chemotherapy medication errors in a national error reporting database. Cancer 2007, 110:186-195.
30. Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. International Journal for Quality in Health Care 2003, 15(1):i49-i59. Suppl.
31. Sano HS, Waddell JA, Solimando A, Doulaveris P, Myhand R. Study of the effect of standardized chemotherapy order forms on prescribing errors and anti-emetic cost. Journal of Oncology Pharmacy Practice 2005, 11:21-30.
32. Schulmeister L. Chemotherapy medication errors: descriptions, severity, and contributing factors. Oncology Nursing Forum 1999, 26:1033-1042.
33. Schwappach D, Boluarte T. The emotional impact of medical error involvement on physicians: a call for leadership and organizational accountability. Swiss Medical Weekly 2008
34. Schwappach DL. Against the silence': development and first results of a patient survey to assess experiences of safety-related events in hospital. BMC Health Services Research 2008, 8:59.
35. Schwappach DLB. Engaging patients as vigilant partners in safety. A systematic review. Medical Care Research and Review 2009, in press
36. Taylor JA, Winter L, Geyer LJ, Hawkins DS. Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer 2006, 107:1400-1406.
37. Unruh KT, Pratt W. Patients as actors: the patient's role in detecting, preventing, and recovering from medical errors. International Journal of Medical Informatics 2006, 76(Suppl. 1):S236-S244.
38. Vincent CA, Coulter A. Patient safety: what about the patient? Quality and Safety in Health Care 2002, 11:76-80.
39. Voeffray M, Pannatier A, Stupp R, Fucina N, Leyvraz S, Wasserfallen JB. Effect of computerisation on the quality and safety of chemotherapy prescription. Quality and Safety in Health Care 2006, 15:418-421.
40. Waterman AD, Gallagher TH, Garbutt J, Waterman BM, Fraser V, Burroughs TE. Hospitalized patients' attitudes about and participation in error prevention. Journal of General Internal Medicine 2006, 21:367-370.
41. Weingart SN, Toth M, Eneman J, Aronson MD, Sands DZ, Ship AN, Davis RB, Phillips RS. Lessons from a patient partnership intervention to prevent adverse drug events. International Journal for Quality in Health Care 2004, 16:499-507.
42. Weingart SN, Pagovich O, Sands DZ, Li JM, Aronson MD, Davis RB, Bates DW, Phillips RS. What can hospitalized patients tell us about adverse events? Learning from patient-reported incidents. Journal of General Internal Medicine 2005, 20:830-836.
43. Weingart SN, Price J, Duncombe D, Connor M, Sommer K, Conley KA, Bierer BE, Ponte PR. Patient-reported safety and quality of care in outpatient oncology. Joint Commission Journal on Quality and Patient Safety 2007, 33:83-94.
44. Weissman JS, Schneider EC, Weingart SN, Epstein AM, David-Kasdan J, Feibelmann S, Annas CL, Ridley N, Kirle L, Gatsonis C. Comparing patient-reported hospital adverse events with medical record review: do patients know something that hospitals do not? Annals of Internal Medicine 2008, 149:100-108.
45. Womer RB, Tracy E, Soo-Hoo W, Bickert B, DiTaranto S, Barnsteiner JH. Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains. Journal of Clinical Oncology 2002, 20:4705-4712.
46. Zernikow B, Michel E, Fleischhack G, Bode U. Accidental iatrogenic intoxications by cytotoxic drugs: error analysis and practical preventive strategies. Drug Safety 1999, 21:57-74.